Evidence map›Paper›PMID 38359291›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis.

Bingteng Xie, Mengdi Zhang, Jie Li, Jianxin Cui, Pengju Zhang, Fangming Liu, Yuxi Wu, Weiwei Deng, Jihong Ma, Xinyu Li and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 202 papers.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed
44.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

202 citing papers in PubMed, 191 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Lactate Signal: Modulator of Cellular Energy Production and Anabolism.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. CD112 Lactylation Drives Dual Immune Evasion From CD8+ T Cells and NK Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Research progress of lactylation modification in tumors (Review).Experimental and therapeutic medicine · 2026
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Bingteng Xie *Key Laboratory of Molecular Medicine and Biological Diagnosis and Treatment (Ministry of Industry and Information Technology), School of Life Science, Beijing Institute of Technology, Beijing 100081, China.ORCID 0000-0003-0113-7298
Mengdi Zhang *State Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.ORCID 0009-0004-8378-7845
Jie Li *State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 10091, China.
Jianxin CuiDepartment of General Surgery & Institute of General Surgery, the First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100583, China.
Pengju ZhangState Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
Fangming LiuState Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
Yuxi WuDepartment of Chemistry, University of Virginia, Charlottesville, VA 22904.
Weiwei DengState Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.
Jihong MaState Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 10091, China.
Xinyu LiState Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 10091, China.
Bingchen PanKey Laboratory of Molecular Medicine and Biological Diagnosis and Treatment (Ministry of Industry and Information Technology), School of Life Science, Beijing Institute of Technology, Beijing 100081, China.
Baohui ZhangDepartment of Physiology, School of Life Science, China Medical University, Shenyang 110122, China.ORCID 0009-0009-3543-8516
Hongbing ZhangState Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.ORCID 0000-0001-6291-1027
Aiqin LuoKey Laboratory of Molecular Medicine and Biological Diagnosis and Treatment (Ministry of Industry and Information Technology), School of Life Science, Beijing Institute of Technology, Beijing 100081, China.
Yinzhe XuFaculty of Hepato-Biliary-Pancreatic Surgery, the First Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100583, China.
Mo LiState Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 10091, China.ORCID 0000-0001-7005-7545
Yang PuState Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Department of Physiology, Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China.ORCID 0000-0001-7390-1510
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CNBeijing Institute of Technology · CNChina Medical University · CNChinese People's Liberation Army · CNPeople's Liberation Army No. 150 Hospital · CNUniversity of Virginia · US

Funding

| Beijing Municipal Natural Science Foundation () Z220011| Beijing Nova Program 2022062Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences 2021-1-I2M-018Haihe Laboratory of Cell Ecosystem Innovation Fund 22HHXBSS00012MOST | National Natural Science Foundation of China (NSFC) 32100554MOST | National Natural Science Foundation of China (NSFC) 82273163MOST | National Natural Science Foundation of China (NSFC) 82371640MOST | National Natural Science Foundation of China (NSFC) T2225006National Science and Technology Major Project () 2021YFC2502000
6 · The paper itself

Abstract

Aberrant lysine lactylation (Kla) is associated with various diseases which are caused by excessive glycolysis metabolism. However, the regulatory molecules and downstream protein targets of Kla remain largely unclear. Here, we observed a global Kla abundance profile in colorectal cancer (CRC) that negatively correlates with prognosis. Among lactylated proteins detected in CRC, lactylation of eEF1A2K408 resulted in boosted translation elongation and enhanced protein synthesis which contributed to tumorigenesis. By screening eEF1A2 interacting proteins, we identified that KAT8, a lysine acetyltransferase that acted as a pan-Kla writer, was responsible for installing Kla on many protein substrates involving in diverse biological processes. Deletion of KAT8 inhibited CRC tumor growth, especially in a high-lactic tumor microenvironment. Therefore, the KAT8-eEF1A2 Kla axis is utilized to meet increased translational requirements for oncogenic adaptation. As a lactyltransferase, KAT8 may represent a potential therapeutic target for CRC.

Indexed as

Colorectal NeoplasmsProtein BiosynthesisCarcinogenesisCatalysisCell Transformation, NeoplasticHistone AcetyltransferasesHumansTumor MicroenvironmentHistone AcetyltransferasesKAT8 protein, humancolorectal cancerlactylationlactyltransferaseprotein synthesis

Identifiers

PMID38359291
PMCPMC10895275
OpenAlexW4391839219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.